Document is current
Any future updates will be listed below
-
Authors
Hu, Xingdi
Wildman, Kingsley P.
Basu, Subham
Lin, Peggy L.
Rowntree, Clare
Saha, Vaskar https://orcid.org/0000-0002-2916-9649
-
Funding
Funding for this research was provided by:
Baxalta (Study sponsor)
Shire (Funded medical writing support)
Servier (Funded medical writing support and publication charges)
- License Information
-
More Information
Article History
Received: 2 April 2019
Accepted: 10 December 2019
First Online: 29 December 2019
Ethics approval and consent to participate
: Not applicable (No human subjects were involved in this cost-effectiveness analysis).
: All authors have consented to publication of this manuscript in BMC Health Economics Review and fulfil all authorship criteria as defined by the International Committee of Medical Journal Editors ().
: Subham Basu, Peggy Lin and Xingdi Hu were employees of Baxalta (now a member of the Takeda group of companies) at the time of the study. Kingsley P. Wildman was a Shire (now a member of the Takeda group of companies) employee at the time of the current study, and he has also previously been an employee of Servier. Vaskar Saha has received research grant funding from Shire, and a speakers fee for I-BFM 2018. Clare Rowntree has participated in a Shire-sponsored video project.
